Global Facial Injectable Market By Product (Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), & Polymer Fillers), By Application (Aesthetics, & Therapeutics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Facial Injectable Market Overview:

The market for facial injectables was worth USD 14,700 million in 2021. It is projected to grow at a CAGR of 9.3% between 2023 and 2032.

In recent years, facial injectables have seen a rise in demand due to consumers’ increasing focus on their physical appearance. Market growth is also driven by the increasing awareness of minimally invasive procedures, as well as various beauty campaigns organized by market leaders. Video calls have been increasing due to the ongoing COVID-19 epidemic. The ‘Zoom Boom’ is a term that describes an increase in awareness about one’s appearance. Botox is a popular cosmetic surgery that has seen an increase in demand.

Global Facial Injectable Market Scope:

Product Analysis

Botulinum Toxin Type A dominated the market, accounting for 53.8% of the total revenue in 2021. Women in their middle years are more likely to use fillers and injectables, including Botox, to reverse the effects of aging. The fastest CAGR for Hyaluronic Acid (HA), is 9.2% over the forecast period. It is well-known for its ability to retain moisture in the skin. This makes the skin appear healthier. HA is known for its moisture-binding property, which helps to maintain and enhance the skin’s plumpness. Cosmetic-grade, HA is low in molecular weight. This allows for deep penetration into the epidermis. It also retains water and releases antioxidants to slow down the aging process.

Application Analysis

The market’s largest segment, aesthetics, accounted for 68.6% of the total revenue in 2021. This is due to an increasing number of facial injectables used for aesthetic procedures like wrinkles on the skin, lip lines, and facial lines. Market growth is expected to be boosted by factors such as rising disposable income and increasing awareness of aesthetic procedures. Market growth will be supported by an increase in facial injectables to treat wrinkles, parentheses, lips, lip augmentation, lip border repair, perioral lines, and crow’s foot lines.

In the next few years, facial injectables will be in high demand due to the growing interest in aesthetics and the increase in disposable income in middle-class countries like India. Over the forecast period, the therapeutic segment will see a double-digit increase in CAGR. This can be attributed to the increasing use of facial injectables for the treatment of blepharospasm and strabismus, Meige’s Syndrome, Oromandibular Dystonia, Hemifacial Spasms, and focal hyperhidrosis.

Key Market Segments:

By Product

• Collagen
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Polymer Fillers
  • Polymethylmethacrylate beads (PMMA Microspheres)
  • Poly-L-Lactic Acid (PLLA)

By Application

• Aesthetics
• Therapeutics

Market Dynamics:

Cosmetic surgery is becoming more popular due to the ease of recovery and the ability to stay at home. The market saw a surge during the pandemic, and the trend is expected to continue. Market revenue will be boosted by the presence of key players such as Allergan, Sinclair Pharma, and Galderma, which have a wide range of injectable fillers that treat a variety of skin conditions like wrinkles, pigmentation, or plumping of lips. The market will be driven by increasing social media exposure, increased effectiveness, approvals, and a growing desire to look young and attractive.

Invasive surgeries are being replaced by minimally invasive procedures. According to the American Society of Plastic Surgeons, there were nearly 17 million minimally-invasive and surgical cosmetic procedures performed in the U.S. in 2020. Nearly 15 million of these products were minimally invasive. The market is growing because of the increased adoption of minimally invasive procedures and the wide variety of treatment options available. The United States ranked number 1 among all countries for non-surgical products. Injectables like botulinum toxins and Hyaluronic Acid were the most in demand. With over 6,000 surgeons, the country has access to advanced treatments and is the most developed in the world. These factors are important for market growth.

Regional Analysis:

North America was the dominant market, accounting for more than 44.0% of the total revenue in 2021. This is due to the high geriatric population of the U.S.A and Canada, which is expected to drive the demand for facial injections in the future. The American Society of Plastic Surgeons (ASPS) compared the rate of growth in cosmetic surgery products between 2000 and 2019. The use of Botox injections grew by 850%, according to the ASPS. In the future, North America will be a major revenue source for facial injectables. The Asia Pacific market will see the highest CAGR at 9.8% over the forecast period. Countries such as South Korea, Australia, and India are supporting the region. The demand for facial injections will rise due to the growing focus on physical appearance in these countries. India is expected to grow at the fastest rate during the forecast period.

Key Regions and Countries covered in the report:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

The major players are focusing their efforts on growth strategies such as technological enhancements, geographic expansion, product launches, and product approvals. In February 2020 Sinclair Pharma granted Galderma SA distribution rights to Sculptra (polylactic acid injectable). In 2019, Allergan also launched a TV commercial for Botox Cosmetics, a brand that caters to millennials. According to the American Academy of Facial and Reconstructive surgery, Botox injections have seen a 23% increase in popularity among those aged 23 to 38 over the past five years. This is based on the date that the product was launched by the company. The following are some of the most prominent players in the facial injectables market:

Market Key Players:

• Ipsen
• Merz Pharma
• Suneva Medical Inc.
• Medytox Inc.
• Sinclair Pharma
• Bloomage Biotechnology Corporation Limited
• Anika Therapeutics Inc.
• Prollenium Medical Technologies
• Allergan Inc.
• Other Key Players

For the Facial Injectable Market research study, the following years have been considered to estimate the market size: